Lv3
260 积分 2025-07-30 加入
Enhancement of EPR Effect for Passive Tumor Targeting: Current Status and Future Perspectives
11天前
已完结
Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma
1个月前
已关闭
Sialic acids in cancer biology and immunity
6个月前
已完结
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
6个月前
已完结
Emerging epigenetic-modulating therapies in lymphoma
6个月前
已完结
Emerging epigenetic-modulating therapies in lymphoma
6个月前
已关闭
Emerging epigenetic-modulating therapies in lymphoma
6个月前
已关闭
Barriers and solutions for CAR-T therapy in solid tumors
6个月前
已完结
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas
6个月前
已完结
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
6个月前
已完结
皖公网安备34019202002308
